Oxidized LDL-anti-oxidized LDL immune complexes and diabetic nephropathy
- PMID: 12436340
- DOI: 10.1007/s00125-002-0962-y
Oxidized LDL-anti-oxidized LDL immune complexes and diabetic nephropathy
Abstract
Aims/hypothesis: Oxidized LDL is immunogenic and immune complexes formed by oxidized LDL and corresponding antibodies are pro-atherogenic and pro-inflammatory. Considering that macroalbuminuria is a risk factor for coronary heart disease and that common pathogenic factors for atherosclerosis and glomerulosclerosis exist, our aim was to determine whether the amount and/or characteristics of oxidized LDL- anti-oxidized LDL complexes correlated with the degree of albuminuria in patients with Type I (insulin-dependent) diabetes mellitus.
Methods: We studied 33 macroalbuminuric patients (albumin excretion rate >300 mg/24 h) and 29 microalbuminuric patients (albumin excretion rate >or=30 mg/24 h and <or=300 mg/24 h) who were matched for age, sex and HbA(1C) concentrations with 43 patients with normal albuminuria. In all patients we isolated and characterized oxidized LDL-anti-oxidized LDL complexes. A subgroup of 47 patients (22 with normal albuminuria, 11 with microalbuminuria, and 14 with macroalbuminuria) was randomly selected from the larger group for characterization of the antibody moiety of oxidized LDL immune complexes.
Results: The concentrations of oxidized LDL immune complexes were increased in patients with macroalbuminuria (total cholesterol in immune complexes isolated from patients with macroalbuminuria was 272+/-20 vs 204+/-18 micro g/ml in patients with normoalbuminuria, p<0.03). Also, the Kd of oxLDL antibodies isolated from the immune complexes was lower in patients with abnormal albuminuria than in patients with normoalbuminuria (0.86+/-0.1x10(-8) vs 1.13+/-0.1x10(-8) mol/l, p<0.05).
Conclusion/interpretation: The data indicate that high concentrations of oxidized LDL-anti-oxidized LDL complexes, particularly when formed with antibodies of higher avidity, are associated with abnormal proteinuria.
Similar articles
-
Antibodies to oxidized LDL and LDL-containing immune complexes as risk factors for coronary artery disease in diabetes mellitus.Clin Immunol. 1999 Feb;90(2):165-72. doi: 10.1006/clim.1998.4631. Clin Immunol. 1999. PMID: 10080827
-
Soluble LDL-immune complexes in type 2 diabetes and vascular disease.Horm Metab Res. 2002 Apr;34(4):196-201. doi: 10.1055/s-2002-26706. Horm Metab Res. 2002. PMID: 11987029
-
The effects of metabolic control on oxidized low-density lipoprotein antibodies in children and adolescents with type 1 diabetes mellitus.Pediatr Diabetes. 2008 Feb;9(1):17-22. doi: 10.1111/j.1399-5448.2007.00281.x. Pediatr Diabetes. 2008. PMID: 18211632
-
Pathogenic role of modified LDL antibodies and immune complexes in atherosclerosis.J Atheroscler Thromb. 2013;20(10):743-54. doi: 10.5551/jat.19281. Epub 2013 Aug 20. J Atheroscler Thromb. 2013. PMID: 23965492 Review.
-
Modified low density lipoprotein and lipoprotein-containing circulating immune complexes as diagnostic and prognostic biomarkers of atherosclerosis and type 1 diabetes macrovascular disease.Int J Mol Sci. 2014 Jul 21;15(7):12807-41. doi: 10.3390/ijms150712807. Int J Mol Sci. 2014. PMID: 25050779 Free PMC article. Review.
Cited by
-
Clinical significance of the humoral immune response to modified LDL.Clin Immunol. 2010 Jan;134(1):55-65. doi: 10.1016/j.clim.2009.04.001. Epub 2009 May 8. Clin Immunol. 2010. PMID: 19427818 Free PMC article. Review.
-
Oxidized LDL immune complexes and coronary artery calcification in type 1 diabetes.Atherosclerosis. 2011 Feb;214(2):462-7. doi: 10.1016/j.atherosclerosis.2010.11.012. Epub 2010 Nov 17. Atherosclerosis. 2011. PMID: 21156319 Free PMC article. Clinical Trial.
-
Lipoprotein autoantibodies: measurement and significance.Clin Diagn Lab Immunol. 2003 Jul;10(4):499-505. doi: 10.1128/cdli.10.4.499-505.2003. Clin Diagn Lab Immunol. 2003. PMID: 12853376 Free PMC article. Review. No abstract available.
-
High levels of oxidized LDL in circulating immune complexes are associated with increased odds of developing abnormal albuminuria in Type 1 diabetes.Nephrol Dial Transplant. 2012 Apr;27(4):1416-23. doi: 10.1093/ndt/gfr454. Epub 2011 Aug 19. Nephrol Dial Transplant. 2012. PMID: 21856760 Free PMC article. Clinical Trial.
-
Association of macroalbuminuria with oxidized LDL and TGF-beta in type 2 diabetic patients: a case-control study.Int Urol Nephrol. 2010 Jun;42(2):487-92. doi: 10.1007/s11255-009-9643-9. Epub 2009 Sep 19. Int Urol Nephrol. 2010. PMID: 19768565
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous